QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer

NCT00807612 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped Study was closed due to administrative decision

Conditions

Advanced Squamous Non-Small Cell Lung Cancer

Interventions

BIOLOGICAL: AMG 479
BIOLOGICAL: AMG 479
DRUG: Carboplatin
BIOLOGICAL: AMG 479
DRUG: Paclitaxel

Sponsor

NantCell, Inc.